Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

alzchem group ag - ALZCF

ALZCF

Close Chg Chg %
168.16 1.34 0.80%

Open Market

169.50

+1.34 (0.80%)

Volume: 200.00

Last Updated:

Sep 12, 2025, 11:31 AM EDT

Trade Now

Company Overview: alzchem group ag - ALZCF

ALZCF Key Data

Open

$169.28

 Day Range

169.28 - 169.50

52 Week Range

48.49 - 174.46

 Market Cap

$1.69B

Shares Outstanding

10.10M

 Public Float

4.32M

Beta

90,837.70

 Rev. Per Employee

N/A

P/E Ratio

26.92

 EPS

-$380.46

Yield

116.50%

 Dividend

$2.03

EX-DIVIDEND DATE

May 9, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

46.68

  

ALZCF Performance

1 Week
 
 0.00%
 
1 Month
 
 2.85%
 
3 Months
 
 209.02%
 
1 Year
 
 N/A
 
5 Years
 
 N/A
 

ALZCF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About alzchem group ag - ALZCF

Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment focuses on the production and distribution of growth products that contain specialty chemicals such as CreAMINO, Creapure, BioSelect, Silzot, DYHARD, and Dormex. The Basics & Intermediates segment covers the production of basic and intermediate products. The Other & Holding segment comprises of services to the chemical parks in Trostberg and Hart. The company was founded on October 10, 1984 is headquartered in Trostberg, Germany.

ALZCF At a Glance

Alzchem Group AG
Chemiepark Trostberg
Trostberg, Bayern (Bavaria) 83308
Phone 49-86-2186-2888 Revenue 599.51M
Industry Chemicals: Major Diversified Net Income 58.49M
Sector Process Industries 2024 Sales Growth 2.567%
Fiscal Year-end 12 / 2025 Employees 1,752
View SEC Filings

ALZCF Valuation

P/E Current 26.916
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 10.267
Price to Sales Ratio 1.002
Price to Book Ratio 2.815
Price to Cash Flow Ratio 5.28
Enterprise Value to EBITDA 5.504
Enterprise Value to Sales 0.98
Total Debt to Enterprise Value 0.093

ALZCF Efficiency

Revenue/Employee 342,184.104
Income Per Employee 33,386.089
Receivables Turnover 6.496
Total Asset Turnover 1.236

ALZCF Liquidity

Current Ratio 2.484
Quick Ratio 1.524
Cash Ratio 0.64

ALZCF Profitability

Gross Margin 29.425
Operating Margin 13.051
Pretax Margin 13.594
Net Margin 9.757
Return on Assets 12.059
Return on Equity 29.891
Return on Total Capital 21.864
Return on Invested Capital 23.69

ALZCF Capital Structure

Total Debt to Total Equity 25.70
Total Debt to Total Capital 20.446
Total Debt to Total Assets 10.918
Long-Term Debt to Equity 21.119
Long-Term Debt to Total Capital 16.801
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alzchem Group Ag - ALZCF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
499.14M 569.86M 584.50M 599.51M
Sales Growth
+15.45% +14.17% +2.57% +2.57%
Cost of Goods Sold (COGS) incl D&A
378.33M 454.89M 436.88M 423.10M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
28.93M 26.85M 28.00M 28.47M
Depreciation
28.14M 26.08M 27.20M 27.43M
Amortization of Intangibles
790.75K 768.26K 797.86K 1.04M
COGS Growth
+15.46% +20.24% -3.96% -3.15%
Gross Income
120.81M 114.97M 147.62M 176.41M
Gross Income Growth
+15.41% -4.84% +28.40% +19.50%
Gross Profit Margin
+24.20% +20.18% +25.26% +29.43%
2021 2022 2023 2024 5-year trend
SG&A Expense
69.44M 78.33M 76.12M 79.15M
Research & Development
11.45M 11.34M 12.34M 11.72M
Other SG&A
57.99M 67.00M 63.78M 67.43M
SGA Growth
+17.08% +12.80% -2.83% +3.98%
Other Operating Expense
9.96M 10.03M 15.03M 19.02M
Unusual Expense
- - - (5.49M)
-
EBIT after Unusual Expense
41.41M 32.11M 56.48M 78.24M
Non Operating Income/Expense
2.81M 12.57M (1.56M) 5.74M
Non-Operating Interest Income
760.01K 813.45K 412.99K 1.78M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.07M 1.29M 2.83M 2.48M
Interest Expense Growth
-14.26% +21.12% +118.62% -12.08%
Gross Interest Expense
1.07M 1.29M 2.83M 2.48M
Interest Capitalized
- - - -
-
Pretax Income
43.16M 43.39M 52.10M 81.50M
Pretax Income Growth
+39.19% +0.53% +20.08% +56.43%
Pretax Margin
+8.65% +7.61% +8.91% +13.59%
Income Tax
10.34M 11.62M 14.48M 22.82M
Income Tax - Current - Domestic
10.69M 5.14M 16.33M 21.76M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(353.41K) 6.48M (1.85M) 1.06M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
32.82M 31.76M 37.61M 58.68M
Minority Interest Expense
202.12K 179.72K 184.87K 184.97K
Net Income
32.61M 31.58M 37.43M 58.49M
Net Income Growth
+45.27% -3.16% +18.51% +56.27%
Net Margin Growth
+6.53% +5.54% +6.40% +9.76%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
32.61M 31.58M 37.43M 58.49M
Preferred Dividends
- - - -
-
Net Income Available to Common
32.61M 31.58M 37.43M 58.49M
EPS (Basic)
3.2142 3.1161 3.6805 5.7491
EPS (Basic) Growth
+45.69% -3.05% +18.11% +56.20%
Basic Shares Outstanding
10.15M 10.14M 10.17M 10.17M
EPS (Diluted)
3.2142 3.1161 3.6805 5.7491
EPS (Diluted) Growth
+45.69% -3.05% +18.11% +56.20%
Diluted Shares Outstanding
10.15M 10.14M 10.17M 10.17M
EBITDA
70.34M 53.46M 84.48M 106.71M
EBITDA Growth
+15.11% -24.00% +58.03% +26.31%
EBITDA Margin
+14.09% +9.38% +14.45% +17.80%

Alzchem Group Ag in the News